Literature DB >> 32410180

Does Chemotherapy-Induced Liver Injury Impair Postoperative Outcomes After Laparoscopic Liver Resection for Colorectal Metastases?

Maud Neuberg1, Ioannis Triantafyllidis1,2, Marine Lefevre3, Mostefa Bennamoun4, Anthony Sarran5, Marc Beaussier1, Christophe Louvet4, Brice Gayet1, David Fuks6.   

Abstract

BACKGROUND: Chemotherapy-associated liver injuries (CALI) have been associated with poor postoperative outcome after open liver resection. To date, no data concerning any correlation of CALI and laparoscopic liver resection (LLR) are available. In the present study, we evaluated the impact of CALI on short-term outcomes in patients undergoing LLR.
MATERIALS AND METHODS: All patients who underwent in our department LLR for colorectal liver metastases (CRLM) from 2000 to 2016 were retrospectively reviewed. Patients were divided in 4 groups according to their pathological histology. In group 1 patients had normal liver parenchyma. Group 2 included patients with steatosis and steatohepatitis. Patients with sinusoidal obstruction syndrome (SOS) and nodular regenerative hyperplasia (NRH) were allocated to group 3, whereas the remaining with fibrosis and cirrhosis, were assigned to group 4.
RESULTS: A total of 490 LLR for CRLM were included in the study. Perioperative details and morbidity did not differ significantly between the four groups. Subgroup analysis showed that NRH was associated with higher amount of blood loss (p = 0.043), overall (p = 0.021) and liver-specific morbidity (p = 0.039).
CONCLUSION: NRH is a severe form of CALI that may worsen the short-term outcomes of patients undergoing LLR for CRLM. However, the remaining forms of CALI do not have a significant impact on perioperative outcomes after LLR.

Entities:  

Keywords:  CALI; Chemotherapy; Colorectal liver metastases; Laparoscopic liver resection; Postoperative outcomes

Year:  2020        PMID: 32410180     DOI: 10.1007/s11605-020-04636-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  48 in total

1.  Fatty liver change as a result of hepatic artery infusion chemotherapy.

Authors:  J Zeiss; H W Merrick; E R Savolaine; L S Woldenberg; K Kim; P J Schlembach
Journal:  Am J Clin Oncol       Date:  1990-04       Impact factor: 2.339

2.  Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

Authors:  Jean-Nicolas Vauthey; Timothy M Pawlik; Dario Ribero; Tsung-Teh Wu; Daria Zorzi; Paulo M Hoff; Henry Q Xiong; Cathy Eng; Gregory Y Lauwers; Mari Mino-Kenudson; Mauro Risio; Andrea Muratore; Lorenzo Capussotti; Steven A Curley; Eddie K Abdalla
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

3.  Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort.

Authors:  Paul Beamish; Madeline Lemke; Jennifer Li; Elijah Dixon; Mauro T Abraham; Roberto Hernandez-Alejandro; Sean Bennett; Guillaume Martel; Paul J Karanicolas
Journal:  HPB (Oxford)       Date:  2017-05-08       Impact factor: 3.647

4.  Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.

Authors:  Luca Viganò; Lorenzo Capussotti; Giovanni De Rosa; Wassila Oulhaci De Saussure; Gilles Mentha; Laura Rubbia-Brandt
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

5.  Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Authors:  René Adam; Valérie Delvart; Gérard Pascal; Adrian Valeanu; Denis Castaing; Daniel Azoulay; Sylvie Giacchetti; Bernard Paule; Francis Kunstlinger; Odile Ghémard; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

6.  Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Authors:  Hiroshi Nakano; Elie Oussoultzoglou; Edoardo Rosso; Selenia Casnedi; Marie-Pierre Chenard-Neu; Patrick Dufour; Philippe Bachellier; Daniel Jaeck
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

Review 7.  Epidemiology of colorectal liver metastases.

Authors:  Donald C McMillan; Colin S McArdle
Journal:  Surg Oncol       Date:  2007-05-09       Impact factor: 3.279

8.  Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.

Authors:  Peter J Allen; Nancy Kemeny; William Jarnagin; Ronald DeMatteo; Leslie Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

9.  Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Authors:  L Rubbia-Brandt; V Audard; P Sartoretti; A D Roth; C Brezault; M Le Charpentier; B Dousset; P Morel; O Soubrane; S Chaussade; G Mentha; B Terris
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

10.  Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer.

Authors:  P D Peppercorn; R H Reznek; P Wilson; M L Slevin; R K Gupta
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.